| Jennifer Phan, MD | |
|
3113 N Broadway Street, Anderson, IN 46012-1261 | |
| (765) 298-4660 | |
| Not Available |
| Full Name | Jennifer Phan |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 15 Years |
| Location | 3113 N Broadway Street, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861621880 | NPI | - | NPPES |
| P01723972 | Other | IN | RR MEDICARE |
| 201110020 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 11014885A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Howard Regional Health Inc. | Kokomo, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Physicians Of Indiana Inc | 1759416662 | 1319 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
Meanwhile, NPR reports on how an abortion rights organization finds the GOP presidential field lacking when it comes to candidates and their positions regarding abortion rights.
Nile Therapeutics, Inc. has announced that, in the course of reviewing the Investigational New Drug (IND) application materials that Nile submitted to the U.S. Food and Drug Administration (FDA) to support the initiation of the Company's Phase IIb clinical trial with CD-NP for the treatment of acute heart failure, the FDA has placed CD-NP on clinical hold.
It is like being in a dirty glass jar, unable to reach out and with acquaintances passing by without saying hello. New research from the Sahlgrenska Academy paints a merciless picture of life with acquired deaf-blindness.
› Verified 5 days ago
| Entity Name | Community Physicians Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619105244 PECOS PAC ID: 1759416662 Enrollment ID: O20100317000717 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
Meanwhile, NPR reports on how an abortion rights organization finds the GOP presidential field lacking when it comes to candidates and their positions regarding abortion rights.
Nile Therapeutics, Inc. has announced that, in the course of reviewing the Investigational New Drug (IND) application materials that Nile submitted to the U.S. Food and Drug Administration (FDA) to support the initiation of the Company's Phase IIb clinical trial with CD-NP for the treatment of acute heart failure, the FDA has placed CD-NP on clinical hold.
It is like being in a dirty glass jar, unable to reach out and with acquaintances passing by without saying hello. New research from the Sahlgrenska Academy paints a merciless picture of life with acquired deaf-blindness.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Phan, MD 6626 E 75th St, Suite 500, Indianapolis, IN 46250-2805 Ph: () - | Jennifer Phan, MD 3113 N Broadway Street, Anderson, IN 46012-1261 Ph: (765) 298-4660 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
Meanwhile, NPR reports on how an abortion rights organization finds the GOP presidential field lacking when it comes to candidates and their positions regarding abortion rights.
Nile Therapeutics, Inc. has announced that, in the course of reviewing the Investigational New Drug (IND) application materials that Nile submitted to the U.S. Food and Drug Administration (FDA) to support the initiation of the Company's Phase IIb clinical trial with CD-NP for the treatment of acute heart failure, the FDA has placed CD-NP on clinical hold.
It is like being in a dirty glass jar, unable to reach out and with acquaintances passing by without saying hello. New research from the Sahlgrenska Academy paints a merciless picture of life with acquired deaf-blindness.
› Verified 5 days ago
Dr. Fernando Javier Morell Diaz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961 | |
James Milligan, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961 Fax: 765-642-0408 | |
Scott C Swim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961 | |
Joshua B Greene, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961 | |
Ronald J Blevins, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961 | |
Peter Nielsen Schilt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961 |